Kneat builds a compliance-focused validation platform for BioPharma and Medical Device manufacturers operating under 21 CFR Part 11 and EudraLex Annex 11. The stack is enterprise-grade (.NET, React, AWS, Salesforce, Redshift) with heavy testing and QA tooling (Selenium, SpecFlow), reflecting the regulatory risk baked into the product. Active projects span platform modernization, SaaS architecture, and AI integration—while internal pain points center on scaling (availability, predictable delivery, platform stability)—suggesting the company is refactoring toward next-generation infrastructure as regulatory complexity and customer demand both grow.
Notable leadership hires: Sales Director
Kneat is a Dublin-headquartered public software company specializing in paperless validation solutions for life sciences. The platform eliminates manual, paper-driven validation workflows across equipment qualification, computer system validation, method validation, cold chain management, and cleaning validation—all audit-trail-enabled and compliant with stringent pharmaceutical regulations. Founded in 2006, Kneat operates a 201–500 person organization across Ireland, Canada, and Malaysia, with engineering-focused hiring (13 active roles) balanced against product development, customer implementation, and SaaS platform scaling initiatives.
Kneat's core platform runs on .NET and ASP.NET Core with React front-end, deployed on AWS (including Lambda and Redshift for data). Authentication uses OAuth, SAML, and Amazon Cognito. Testing and CI/CD rely on Selenium, SpecFlow, and Azure Pipelines.
Kneat is headquartered in Limerick, Ireland, and operates offices in Canada and Malaysia. The company is a publicly traded enterprise with 201–500 employees.
Other companies in the same industry, closest in size